Fuso Pharmaceutical Industries,Ltd.

4538

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-10FY2027 Q1

Revenue

628.5100M JPY

YoY +2.3%

Operating Income

9.7100M JPY

YoY +63.1%

Net Income

21.9100M JPY

YoY +163.4%

EPS

75.3JPY

YoY +39.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

623.1億円

459.1億円

295.1億円

131.1億円

-32.9億円

Rev: 496.3億円Op: 19.2億円NI: 14.8億円

Rev: 510.1億円Op: 22.1億円NI: 16.1億円

Rev: 554.1億円Op: 19.6億円NI: 13.8億円

Rev: 605.6億円Op: 41.3億円NI: -32.9億円

Rev: 623.1億円Op: 26.4億円NI: 20.1億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress160.500M

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan